Martin Olovsson
CEO and Co-founder

Martin cofounded OnDosis in 2017 based on a concept from AstraZeneca. He has solid experience from senior roles within the pharmaceutical industry across commercial and development at local, regional and global level. Martin has a past as Global lead for the Respiratory franchise in AstraZeneca and as CEO of the AstraZeneca Nordic-Baltic Region.

Jonas Bäck
Head of Business Development

Jonas has a background of 15 years within the management consulting industry, business development and working with transformation projects. Before joining OnDosis in 2019, he was working at EY Advisory Services, leading strategic projects for clients, for example within healthcare, med tech and pharmacy industry.

Stina Wigren
COO

Stina has worked 15+ years within research, product development and clinical affairs at global implant companies Nobel Biocare and Cochlear. She has significant experience from development of Class I-III medical devices and drug-device combination products. Before joining OnDosis, Stina held a position as Head of Clinical Affairs at Cochlear.

Joshua Carney
Chief Digital Officer

Joshua joined OnDosis in 2021. He has 10+ years of experience from IoT, open innovations, and M&A activities within the Med Tech industry. Joshua specializes in ensuring that scientific breakthroughs are combined with sound business development strategies. He previously held several leading roles within IoT and innovation at Essity.

Johan Brandt
CFO

Johan joined OnDosis in 2022. He has over 15 years’ experience of financial management in both private and listed tech companies and a background as an authorized public accountant at EY, CFO of Nimbus, EVP and CFO of Arcam AB and CFO of Ovzon AB. Johan is also the founder and owner of Axellen AB and Chaiman of the board of Enairon AB.